Symbol: |
NMRK2
|
Description: |
nicotinamide riboside kinase 2 [Source:HGNC Symbol;Acc:17871]
|
Location: |
Chr19:3933101-3942412[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:216
Gene |
Compound |
Gen_sig |
Exp_pattern |
NMRK2 |
NSC 606398 |
0.029 |
Down |
NMRK2 |
Camptothecin ethylglycinate ester hydrochloride |
0.017 |
Up |
NMRK2 |
Camptothecin hemisuccinate sodium salt |
0.032 |
Up |
NMRK2 |
NSC 611274 |
0.015 |
Down |
NMRK2 |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.017 |
Up |
NMRK2 |
NSC 62349 |
0.022 |
Up |
NMRK2 |
NSC 6246 |
0.016 |
Down |
NMRK2 |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.017 |
Down |
NMRK2 |
9-AMINO-20-CAMPTOTHECIN |
0.014 |
Up |
NMRK2 |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.002 |
Down |
NMRK2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.038 |
Up |
NMRK2 |
NSC 639211 |
0.003 |
Down |
NMRK2 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.016 |
Down |
NMRK2 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.021 |
Up |
NMRK2 |
ANTINEOPLASTIC-654379 |
0.03 |
Up |
Expression pattern: Sensitivity / Resistance
Total:15 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:4
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|